Cover Image

P60 Supporting hepatitis C treatment uptake by primary care providers: a successful model

Saved in:

Bibliographic Details
Main Authors:	S. Sheils (Author), S. Mason (Author), F. Tenison (Author), M. Gawrys (Author), J. Pritchard-Jones (Author), H. Longworth (Author), G. McCaughan (Author), P. Haber (Author), S. Strasser (Author)
Format:	Book
Published:	Elsevier, 2017-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

P51 Advanced liver disease nurse education program in NSW
by: J. Pritchard-Jones, et al.
Published: (2017)

Setting foot in private spaces: extending the hepatitis C cascade of care to automatic needle/syringe dispensing machines, a mixed methods study
by: Heidi Coupland, et al.
Published: (2022)

P20 Monitoring the uptake of hepatitis C: direct acting antiviral treatment in Australia
by: B. Hajarizadeh, et al.
Published: (2017)

P18 Treating the mob: providing hepatitis C treatment in an aboriginal community controlled health service is a successful model of care
by: B. Hanley, et al.
Published: (2017)

Health professionals' perceptions of the barriers and facilitators to providing smoking cessation advice to women in pregnancy and during the post-partum period: a systematic review of qualitative research
by: Kate Flemming, et al.
Published: (2016)

P3 Successful treatment of hepatitis C among homeless and socially marginalised clients in primary care
by: N. Andric, et al.
Published: (2017)

P56 Opportunities for hepatitis organisations to compliment needle syringe programs for people who inject drugs by providing hepatitis C treatments
by: S. Rowell, et al.
Published: (2017)

Influential Factors of Successful Hepatitis C Treatment in Elderly Patients
by: Jennifer Andres, et al.
Published: (2019)

Effects of a hard stop for C. difficile testing: Provider uptake and patient outcomes
by: Danielle Doughman, et al.
Published: (2023)

Providing Hepatitis C Treatment Locally for Substance-Using Patients
by: Susan B. Clapp, et al.
Published: (2023)

Provider Workforce Assessment in a Rural Hepatitis C Epidemic
by: Ryan P. Westergaard, et al.
Published: (2015)

Putting a "C<sub>60</sub> Ball" and Chain to Chlorin e6 Improves Its Cellular Uptake and Photodynamic Performances
by: Manuele Di Sante, et al.
Published: (2023)

P65 Nurse-led hepatitis C treatment models in drug and alcohol services can support, treatment uptake, healthcare engagement and community prescribing
by: S. Watkinson, et al.
Published: (2017)

P26 HealthPathways Melbourne: assisting general practitioners and practice nurses to provide optimal care for patients with hepatitis C
by: O. Janover, et al.
Published: (2017)

P1 Hepatitis C CALD community outreach
by: D. Abdelsalam
Published: (2017)

Contribution of prison-based hepatitis C treatment initiations to overall treatment uptake in Victoria, Australia
by: Samara Griffin, et al.
Published: (2024)

The role of insurance providers in supporting treatment and management of hepatitis C patients
by: Masoud Behzadifar, et al.
Published: (2019)

P70 Elimination of hepatitis C in a prison setting
by: C. Lobo, et al.
Published: (2017)

Nurses' and nursing students' reasons for entering the profession: content analysis of open-ended questions
by: Lisa McKenna, et al.
Published: (2023)

P15 Engagement of the notorious mongrel mob and their knowledge of hepatitis C
by: M. Fraser, et al.
Published: (2017)

Hepatitis B vaccine uptake assessment in India
by: Mohan Bairwa
Published: (2014)

Uptake of hepatitis C direct-acting antiviral treatment in China: a retrospective study from 2017 to 2021
by: Xinyu Du, et al.
Published: (2023)

Interventions to Improve Uptake of Direct-Acting Antivirals for Hepatitis C Virus in Priority Populations: A Systematic Review
by: David Ortiz-Paredes, et al.
Published: (2022)

P17 The impact of hepatitis C-related uncertainty on self-reported stress in people who inject drugs living with hepatitis C
by: S. Goutzamanis, et al.
Published: (2017)

Active hepatitis C is associated with a larger HIV reservoir in successfully treated patients
by: Matteo Vassallo, et al.
Published: (2018)

Using Linked Lung Cancer Registry and Hospital Data for Guiding Health Service Improvement
by: David Roder, et al.
Published: (2016)

P34 Expanding access to treatment for patients with hepatitis C through the use of the remote access request form
by: S. Nazareth, et al.
Published: (2017)

RELATIONSHIP BETWEEN MOTOR AND MORPHOLOGICAL CHARACTERISTICS OF STUDENTS WITH SUCCESS IN RUNNING TO 60 METERS
by: Veton Xhemajli, et al.
Published: (2012)

Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access
by: Nick Scott, et al.
Published: (2018)

P57 Taking hepatitis C issues to the homes of Arabic communities in NSW
by: W. Sabri
Published: (2017)

P53 Hepatitis C diagnostic testing trends in Victoria, 2010-2015
by: S.L. Rawson, et al.
Published: (2017)

Successes and challenges of best practice alerts to identify and engage individuals living with hepatitis C virus
by: Saniya Tandon, et al.
Published: (2024)

Automated morphometry provides accurate and reproducible virtual staging of liver fibrosis in chronic hepatitis C
by: Paul Calès, et al.
Published: (2015)

P35 Treatment access for hepatitis C across Australia: mapping need and capacity
by: J.H. MacLachlan, et al.
Published: (2017)

P71 High hepatitis C cure rate in a general practice cohort
by: D. Baker, et al.
Published: (2017)

P44 Maximising access to hepatitis C (HCV) treatment: the Sunshine Coast experience
by: J. O'Beirne, et al.
Published: (2017)

Interaction of Remdesivir with Clinically Relevant Hepatic Drug Uptake Transporters
by: Anne T. Nies, et al.
Published: (2021)

Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60+
by: Cornelia Betsch, et al.
Published: (2018)

P38 Hepatitis NSW's specialised counselling service: professional support for people undertaking DAA treatment for viral hepatitis C
by: L. Pesa, et al.
Published: (2017)

Elbasvir/grazoprevir in women with hepatitis C virus infection taking oral contraceptives or hormone replacement therapy
by: Hézode C, et al.
Published: (2019)